Karmochkine M - Search Results

1

High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension.

Karmochkine M, Cacoub P, Dorent R, Laroche P, Nataf P, Piette JC, Boffa MC, Gandjbakhch I. Karmochkine M, et al. J Rheumatol. 1996 Feb;23(2):286-90. J Rheumatol. 1996. PMID: 8882033

2

Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis.

Karmochkine M, Cacoub P, Piette JC, Godeau P, Boffa MC. Karmochkine M, et al. Clin Exp Rheumatol. 1992 Nov-Dec;10(6):603-5. Clin Exp Rheumatol. 1992. PMID: 1483313

3

[Antiphospholipid syndrome and the pneumologist].

Piette JC, Cacoub P, Karmochkine M, Godeau P. Piette JC, et al. Among authors: karmochkine m. Rev Pneumol Clin. 1994;50(3):99-105. Rev Pneumol Clin. 1994. PMID: 7724979 Review. French.

4

[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?].

Karmochkine M, Piette JC, Mazoyer E, Wechsler B, Chérin P, Herson S, Godeau P, Boffa MC. Karmochkine M, et al. Presse Med. 1995 Feb 4;24(5):267-70. Presse Med. 1995. PMID: 7899382 Review. French.

5

Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.

Berard M, Boffa MC, Karmochkine M, Aillaud MF, Juhan-Vague I, Francès C, Cacoub P, Piette JC, Harlé JR. Berard M, et al. Among authors: karmochkine m. J Lab Clin Med. 1993 Nov;122(5):601-5. J Lab Clin Med. 1993. PMID: 8228579

6

Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus.

Karmochkine M, Berard M, Piette JC, Cacoub P, Aillaud MF, Harlé JR, Godeau P, Boffa MC, Harlet JR. Karmochkine M, et al. Lupus. 1993 Jun;2(3):157-60. doi: 10.1177/096120339300200305. Lupus. 1993. PMID: 8369806

7

Plasma levels of thrombomodulin in pulmonary hypertension.

Cacoub P, Karmochkine M, Dorent R, Nataf P, Piette JC, Godeau P, Gandjbakhch I, Boffa MC. Cacoub P, et al. Among authors: karmochkine m. Am J Med. 1996 Aug;101(2):160-4. doi: 10.1016/s0002-9343(96)80070-2. Am J Med. 1996. PMID: 8757355

8

Heterogeneity of antiphospholipid antibodies and their cofactors.

Boffa MC, Berard M, Karmochkine M. Boffa MC, et al. Among authors: karmochkine m. Clin Rev Allergy Immunol. 1995 Spring;13(1):101-6. doi: 10.1007/BF02772253. Clin Rev Allergy Immunol. 1995. PMID: 7648344 Review. No abstract available.

9

Treatment of the antiphospholipid syndrome.

Piette JC, Karmochkine M, Papo T, Du LT, Francès C, Wechsler B. Piette JC, et al. Among authors: karmochkine m. Clin Rev Allergy Immunol. 1995 Spring;13(1):73-89. doi: 10.1007/BF02772251. Clin Rev Allergy Immunol. 1995. PMID: 7648352 Review. No abstract available.

10

The effect of sera with antiphospholipid antibodies on endothelial cell procoagulant activity is dependent upon the charge of the phospholipids against which they are directed.

Karmochkine M, Bérard M, Piette JC, Cacoub P, Godeau P, Boffa MC. Karmochkine M, et al. Thromb Res. 1994 May 15;74(4):435-40. doi: 10.1016/0049-3848(94)90159-7. Thromb Res. 1994. PMID: 8085244 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page